Structural basis for suppression of a host antiviral response by influenza a virus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 35, 2008, Pages 13093-13098

  Das, Kalyan ^a,b   Ma, Li Chung ^a,b   Xiao, Rong ^a,b   Radvansky, Brian ^a,b   Aramini, James ^a,b   Zhao, Li ^a,c   Marklund, Jesper ^d   Kuo, Rei Lin ^d   Twu, Karen Y ^d   Arnold, Eddy ^a,b   Krug, Robert M ^d   Montelione, Gaetano T ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Antiviral drug discovery; Bird flu; Vaccine engineering; Virology; X ray crystallography

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; BETA INTERFERON; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; MESSENGER RNA; NS1A PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EMBRYO; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RNA PROCESSING; ZINC FINGER MOTIF;

AMINO ACID SUBSTITUTION; BINDING SITES; CELL LINE; CRYSTALLOGRAPHY, X-RAY; HUMANS; INFLUENZA A VIRUS; INTERFERON REGULATORY FACTOR-3; METHIONINE; MODELS, MOLECULAR; PHENYLALANINE; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; THERMODYNAMICS; VIRAL NONSTRUCTURAL PROTEINS; ZINC FINGERS;

AVES; INFLUENZA A VIRUS;

EID: 51349124912     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805213105     Document Type: Article

References (37)

1. Hatada E, Takizawa T, Fukuda R (1992) Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA. in vitro J Gen Virol 73:17-25.
2. Wang W, et al. (1999) RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA 5:195-205.
3. Chien CY, et al. (2004) Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry 43:1950-1962.
4. Min J, Krug RM (2006) The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2′-5′ OAS/RNase L pathway. Proc Natl Acad Sci USA 103:7100-7105.
5. Li S, Min JY, Krug RM, Sen GC (2006) Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13-21.
6. Kim MJ, Latham AG, Krug RM (2002) Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci USA 99:10096-10101.
7. Li Y, Chen ZY, Wang W, Baker CC, Krug RM (2001) The 3′-end- processing factor CPSF is required for the splicing of single-intron pre-mRNAs. in vivo RNA 7:920-931.
8. Nemeroff M, Barabino SML, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the 30 kD subunit of cleavage and specificity factor and inhibits 3′ end formation of cellular pre-mRNAs. Mol Cell 1:991-1000.
9. Noah DL, Twu KY, Krug RM (2003) Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAs. Virology 307:386-395.
10. Shimizu K, Iguchi A, Gomyou R, Ono Y (1999) Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Virology 254:213-219.
11. Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE (2006) Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci USA 103:14194-14199.
12. Shin YK, et al. (2007) SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol 81:12730-12739.
13. Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y (2007) Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88:13-18.
14. Hale BG, Batty IH, Downes CP, Randall RE (2008) Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 283:1372-1380.
15. Min JY, Li S, Sen GC, Krug RM (2007) A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 363:236-243.
16. Chien CY, et al. (1997) A novel RNA-binding motif in influenza A virus non-structural protein 1 Nat Struct Biol 4:891-895.
17. Liu J, et al. (1997) Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol 4:896-899.
18. Yin C, et al. (2007) Conserved surface features form the double-stranded RNA binding site of non-structural protein 1 (NS1) from influenza A and B viruses. J Biol Chem 282:20584-20592.
19. Twu KY, Noah DL, Rao P, Kuo RL, Krug RM (2006) The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80:3957-3965.
20. Twu KY, Kuo RL, Marklund J, Krug RM (2007) The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 81:8112-8121.
21. Macken C, Lu H, Goodman J, Boykin L (2001) in Options for the control of influenza IV, Osterhaus, NC, Hampson, AW, eds (Elsevier Science, Amsterdam), pp 103-106.
22. Hendrickson WA, Horton JR, LeMaster DM (1990) Selenomethionyl proteins produced for analysis by multiwavelength anomalous diffraction (MAD): a vehicle for direct determination of three-dimensional structure. EMBO J 9:1665-1672.
23. Bornholdt ZA, Prasad BV (2006) X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol 13:559-560.
24. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE (2004) Recognition of the mRNA AU-rich element by the zinc finger domain of TIS11d. Nat Struct Mol Biol 11:257-264.
25. Barabino SM, Hübner W, Jenny A, Minvielle-Sebastia L, Keller W (1997) The 30-kD subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins. Genes Dev 11:1703-1716.
26. Geiss GK, et al. (2002) Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc Natl Acad Sci USA 99:10736-10741.
27. Hatta M, Gao P, Halfmann P, Kawaoka Y (2001) Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293:1840-1842.
28. Zitzow LA, et al. (2002) Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 76:4420-4429.
29. Horimoto T, Kawaoka Y (2005) Influenza: Lessons from past pandemics, warnings from current incidents. Nature Revs Microbiol 3:591-600.
30. Noah DL, Krug RM (2005) Influenza virus virulence and its molecular determinants. Adv Virus Res 65:121-145.
31. Wright PF, Webster RG (2001) in Fields Virology, Knipe, DM, Howley, PM, eds (Lippincott Williams & Wilkins, Philadelphia), pp 1533-1579.
32. Kochs G, Garcia-Sastre A, Martinez-Sobrido L (2007) Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 81:7011-7021.
33. Talon J, et al. (2000) Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci USA 97:4309-4314.
34. Ozaki H, et al. (2004) Generation of high-yielding influenza A viruses in African green monkey kidney (Vero) cells by reverse genetics. J Virol 78:1851-1857.
35. Acton TB, et al. (2005) Robotic cloning and protein production platform of the Northeast Structural Genomics Consortium. Methods Enzymol 394:210-243.
36. Iwamura T, et al. (2001) Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375-388.
37. Hale BG, Barclay WS, Randall RE, Russell RJ (2008) Structure of an avian influenza A virus NS1 protein effector domain. Virology 378(1):1-5.